Ultime notizie per Viatris (NASDAQ:VTRS) Azioni

Viatris

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Viatris Inc

<p>Stifel  analyst Brad Reback   maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Buy and raises the price target from $98 to $132.</p>


News

Price Target

Analyst Ratings

ESTC

Stifel Maintains Buy on Elastic, Raises Price Target to $132

<p>Benchmark  analyst Bruce Jackson   maintains Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) with a Buy and lowers the price target from $90 to $84.</p>


CLNN

Benchmark Maintains Buy on Clene, Lowers Price Target to $84

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Raymond James analyst John Ransom downgraded the rating for <strong>HCA Healthcare, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) from Outperform to Market Perform. HCA Healthcare shares closed at $332.24 on Thursday. See how other analysts view this stock.</li>
<li>JMP Securities analyst Matthew Carletti downgraded the rating for <strong>Root, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) from Market Outperform to Market Perform. Root shares closed at $109.40 on Thursday. <a href="https://www.benzinga.com/quote/root/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham analyst Mike Matson downgraded <strong>TransMedics Group, Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) from Buy to Hold and maintained the price target of $109. TransMedics shares closed at $79.34 on Thursday. <a href="https://www.benzinga.com/quote/tmdx/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc analyst Steve Barger downgraded the rating for <strong>The Timken Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKR#NYSE">TKR</a>) from Overweight to Sector Weight. Timken shares closed at $75.22 on Thursday. <a href="https://www.benzinga.com/quote/tkr/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B. Riley Securities analyst Alex Rygiel downgraded <strong>Atkore Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATKR#NYSE">ATKR</a>) from Buy to Neutral and lowered the price target from $135 to $84. Atkore shares closed at $85.14 on Thursday. <a href="https://www.benzinga.com/quote/atkr/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p>Considering buying HCA stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="558" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22095511/image-247-1024x558.png" alt="" class="wp-image-661076" style="width:678px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22095511/image-247-1024x558.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22095511/image-247-300x163.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22095511/image-247-768x418.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22095511/image-247.png 1225w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next:<a href="https://www.benzinga.com/24/11/42135346/top-3-materials-stocks-that-could-blast-off-in-november"> </a></strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/11/42135346/top-3-materials-stocks-that-could-blast-off-in-november">Top 3 Materials Stocks That Could Blast Off In November</a></strong></li>
</ul>


Downgrades

Markets

Trading Ideas

ATKR

ROOT

TMDX

This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

<p>JP Morgan  analyst Mark Murphy   maintains Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Neutral and raises the price target from $600 to $640.</p>


INTU

JP Morgan Maintains Neutral on Intuit, Raises Price Target to $640

<p>Keefe, Bruyette &amp; Woods  analyst Timothy Switzer   maintains Priority Tech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTH#NASDAQ">PRTH</a>) with a Market Perform and raises the price target from $9 to $10.</p>


PRTH

Keefe, Bruyette & Woods Maintains Market Perform on Priority Tech Holdings, Raises Price Target to $10

<p>Keefe, Bruyette &amp; Woods  analyst Catherine Mealor   maintains Atlantic Union Bankshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUB#NYSE">AUB</a>) with a Market Perform and raises the price target from $42 to $46.</p>


Keefe, Bruyette & Woods Maintains Market Perform on Atlantic Union Bankshares, Raises Price Target to $46

<p>JP Morgan  analyst Michael Rehaut   maintains Installed Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBP#NYSE">IBP</a>) with a Neutral and raises the price target from $236 to $241.</p>


JP Morgan Maintains Neutral on Installed Building Prods, Raises Price Target to $241

<p>Benchmark  analyst Fawne Jiang   maintains Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) with a Buy and lowers the price target from $135 to $130.</p>


BIDU

Benchmark Maintains Buy on Baidu, Lowers Price Target to $130

<p>Goldman Sachs  analyst George Tong   maintains Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) with a Neutral and raises the price target from $13.6 to $15.</p>


VSTS

Goldman Sachs Maintains Neutral on Vestis, Raises Price Target to $15

<p>JP Morgan  analyst Jessica Fye   maintains Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) with a Overweight and raises the price target from $74 to $83.</p>


INSM

JP Morgan Maintains Overweight on Insmed, Raises Price Target to $83

<p>Goldman Sachs  analyst Kash Rangan   maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Buy and raises the price target from $73 to $83.</p>


PCOR

Goldman Sachs Maintains Buy on Procore Technologies, Raises Price Target to $83

<p>Deep-pocketed investors have adopted a bearish approach towards Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MU usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for Micron Technology. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 16% leaning bullish and 75% bearish. Among these notable options, 4 are puts, totaling $351,635, and 8 are calls, amounting to $370,510.</p>
<h3>Predicted Price Range</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $87.5 to $115.0 for Micron Technology during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Micron Technology options trades today is 3119.82 with a total volume of 1,872.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Micron Technology's big money trades within a strike price range of $87.5 to $115.0 over the last 30 days.</p>
<h3>Micron Technology Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732287000_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$3.7</td>
<td>$3.6</td>
<td>$3.7</td>
<td>$106.00</td>
<td>$131.3K</td>
<td>845</td>
<td align="right">360</td>
</tr>
<tr>
<td>MU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$19.25</td>
<td>$19.25</td>
<td>$19.25</td>
<td>$115.00</td>
<td>$96.2K</td>
<td>568</td>
<td align="right">150</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$7.35</td>
<td>$7.25</td>
<td>$7.25</td>
<td>$102.00</td>
<td>$72.5K</td>
<td>125</td>
<td align="right">101</td>
</tr>
<tr>
<td>MU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$7.2</td>
<td>$7.15</td>
<td>$7.2</td>
<td>$105.00</td>
<td>$72.0K</td>
<td>6.5K</td>
<td align="right">107</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$18.4</td>
<td>$17.7</td>
<td>$18.4</td>
<td>$87.50</td>
<td>$62.5K</td>
<td>1.3K</td>
<td align="right">34</td>
</tr>
</tbody>
</table>
</p>
<h3>About Micron Technology</h3>
<p>Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.</p>
<h3>Current Position of Micron Technology</h3>
<ul>
<li>With a trading volume of 750,306, the price of MU is up by 0.62%, reaching $103.4.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 26 days from now.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Micron Technology options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

A Closer Look at Micron Technology's Options Market Dynamics

<p>Deep-pocketed investors have adopted a bearish approach towards Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TSLA usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 31 extraordinary options activities for Tesla. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 35% leaning bullish and 54% bearish. Among these notable options, 9 are puts, totaling $570,642, and 22 are calls, amounting to $1,478,348.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $335.0 to $500.0 for Tesla during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Tesla's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Tesla's significant trades, within a strike price range of $335.0 to $500.0, over the past month.</p>
<h3>Tesla Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732286995_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/29/24</td>
<td>$8.15</td>
<td>$8.05</td>
<td>$8.1</td>
<td>$345.00</td>
<td>$213.3K</td>
<td>6.9K</td>
<td>2.7K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$4.0</td>
<td>$3.9</td>
<td>$3.98</td>
<td>$340.00</td>
<td>$205.5K</td>
<td>10.0K</td>
<td>8.3K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$6.55</td>
<td>$6.4</td>
<td>$6.4</td>
<td>$335.00</td>
<td>$186.7K</td>
<td>6.2K</td>
<td>1.3K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$6.4</td>
<td>$6.35</td>
<td>$6.35</td>
<td>$350.00</td>
<td>$160.0K</td>
<td>15.9K</td>
<td>3.4K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$6.75</td>
<td>$6.6</td>
<td>$6.6</td>
<td>$335.00</td>
<td>$145.8K</td>
<td>6.2K</td>
<td>1.2K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Tesla</h3>
<p>Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and a robotaxi. Global deliveries in 2023 were a little over 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.</p>
<p>Following our analysis of the options activities associated with Tesla, we pivot to a closer look at the company's own performance.</p>
<h3>Tesla's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,190,024, with TSLA's price up by 0.88%, positioned at $342.63.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 61 days.</li>
</ul>
<h3>Expert Opinions on Tesla</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $289.6.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from B of A Securities persists with their Buy rating on Tesla, maintaining a target price of $350.<br />
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Tesla, which currently sits at a price target of $287.<br />
&#x2A; An analyst from JP Morgan persists with their Underweight rating on Tesla, maintaining a target price of $135.<br />
&#x2A; An analyst from Wedbush has decided to maintain their Outperform rating on Tesla, which currently sits at a price target of $400.<br />
&#x2A; Showing optimism, an analyst from KGI Securities upgrades its rating to Outperform with a revised price target of $276. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tesla with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


TSLA

Unpacking the Latest Options Trading Trends in Tesla

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Baidu</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BIDU, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Baidu.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 12% bullish and 75%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $173,105, and 4 are calls, for a total amount of $166,300.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $130.0 for Baidu, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Baidu's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Baidu's substantial trades, within a strike price spectrum from $60.0 to $130.0 over the preceding 30 days.</p>
<h3>Baidu Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732286989_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$15.0</td>
<td>$14.6</td>
<td>$14.85</td>
<td>$95.00</td>
<td>$74.2K</td>
<td>71</td>
<td align="right">60</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$13.4</td>
<td>$13.15</td>
<td>$13.15</td>
<td>$110.00</td>
<td>$65.7K</td>
<td>58</td>
<td align="right">52</td>
</tr>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.15</td>
<td>$6.0</td>
<td>$6.15</td>
<td>$75.00</td>
<td>$43.0K</td>
<td>2.1K</td>
<td align="right">75</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$80.00</td>
<td>$35.0K</td>
<td>931</td>
<td align="right">308</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$3.5</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$80.00</td>
<td>$33.2K</td>
<td>931</td>
<td align="right">308</td>
</tr>
</tbody>
</table>
</p>
<h3>About Baidu</h3>
<p>Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.</p>
<p>After a thorough review of the options trading surrounding Baidu, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Current Position of Baidu</h3>
<ul>
<li>With a trading volume of 624,529, the price of BIDU is down by -2.22%, reaching $79.82.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 96 days from now.</li>
</ul>
<h3>Expert Opinions on Baidu</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $115.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Mizuho persists with their Outperform rating on Baidu, maintaining a target price of $115. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Baidu with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Behind the Scenes of Baidu's Latest Options Trends

<p>Goldman Sachs  analyst Kash Rangan   maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Neutral and raises the price target from $99 to $113.</p>


Goldman Sachs Maintains Neutral on Elastic, Raises Price Target to $113

<p>Good Morning Traders! In today&#39;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.</p>
<p>Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.</p>
<p>We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market&#39;s pulse to optimize your trading gains. Now, let&#39;s dive into the stock analysis:</p>
<h3><strong>SPDR S&amp;P 500 ETF Trust </strong></h3>
<p>SPY&nbsp;(ARCA: SPY) is currently trading near our key level of 592.00. For bullish traders, maintaining control above this level is crucial. A successful hold and push higher could bring 593.73 into play. If buyers sustain momentum above 593.73, the next target would be a move towards 596.57, a significant support level. Should this area hold during the session, further upside could drive the price to 598.04, with a high bullish target for the day of 599.24.</p>
<p>On the flip side, failure to maintain 592.00 as support could see bears stepping in to test the downside at 589.71. Sustained selling pressure at this level might push SPY down to 587.31, a critical threshold. If broken, we anticipate a move lower to 585.75, with the low bear target for a sell-off day situated at 584.68.</p>
<h3><strong>Invesco QQQ Trust Series 1</strong></h3>
<p>The QQQ&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qqq#NASDAQ">QQQ</a>) is trading around the significant level of 504.44. Bulls will aim to defend this area and push higher, targeting 506.68 as the next strong support zone. If sustained buying pressure materializes, the next upward move could test 509.87, with a potential climb to 511.53 if the session remains robust. The high bullish target for QQQ today stands at 513.64.</p>
<p>However, if sellers overcome the 504.44 support, we may see a downward move to 502.65. Bearish pressure at this level could pave the way for a test at 501.07. If weakness persists, expect a dip to 499.44, with the day&rsquo;s low bear target resting at 498.37.</p>
<h3><strong>Apple Inc. </strong></h3>
<p>Apple&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) is positioned around 229.03, a critical level for today&rsquo;s session. For bulls to take control, holding above this mark is key. A sustained rally could bring the price to 230.25, and if momentum continues, 231.76 is the next level to watch. A strong bullish session might drive Apple toward the day&rsquo;s high bull target of 233.28.</p>
<p>If 229.03 fails to act as support, bears may seize control and aim for 227.82. Further selling could bring 226.90 into focus. Persistent bearish action could drive the price lower to 226.08, with the low target for a negative session set at 225.31.</p>
<h3><strong>Microsoft Corp. </strong></h3>
<p>Microsoft&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>) is trading around 411.72, a pivotal level for today&rsquo;s action. For bulls, maintaining strength above this point is essential to build momentum. A move to 413.14 could establish a solid base for further gains, with the next targets being 414.56 and the high bull target of 416.32 if the session remains favorable.</p>
<p>Should 411.72 fail to hold, bears could gain traction and push the price to 410.64. A breakdown here may lead to further selling, testing 409.69. If bearish pressure intensifies, 408.46 could come into play, with the low target for the day positioned at 407.11.</p>
<h3><strong>NVIDIA Corporation </strong></h3>
<p>NVIDIA&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) is trading near 145.61, a key level for today&rsquo;s price action. Bulls will aim to reclaim 147.06 and hold it as support, creating room for an upward move toward 148.52. If buying strength persists, the rally could extend to 150.32, with a high bull target of 151.99 for the day.</p>
<p>Failure to hold 145.61 could lead to a bearish session, with a test of 144.21 on the downside. Continued selling pressure might push the price toward 142.35, and if weakness remains, a drop to 141.21 is possible. The low bear target for NVIDIA today is set at 140.28.</p>
<h3><strong>Alphabet Inc Class A</strong></h3>
<p>Alphabet&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) is trading near 167.04, a key level that bulls must defend. A push higher could bring 169.34 into focus, establishing a foundation for further gains toward 171.14. If momentum remains positive, the high bull target for Alphabet today is 172.28.</p>
<p>Conversely, if 167.04 fails to hold, bears may aim for 165.41. Breaking this level could lead to additional downside movement to 163.79, with heavy selling potentially driving the price to a low bear target of 161.79.</p>
<h3><strong>Meta Platforms Inc </strong></h3>
<p>Meta&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meta#NASDAQ">META</a>) is hovering near 559.29, an important level for today&rsquo;s session. Bulls will seek to build momentum above this mark, with 565.53 as the next upside target. Sustained strength could push the price toward 573.25, and if bullish momentum dominates, Meta may reach the high target of 580.17.</p>
<p>If sellers overpower the bulls and break below 559.29, a move to 553.05 is likely. Continued pressure could drive the price lower to 548.44, with a breakdown opening the path toward the day&rsquo;s low target of 541.79.</p>
<h3><strong>Tesla Inc. </strong></h3>
<p>Tesla&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) is trading near 340.97, a critical level for today&rsquo;s action. Bulls will look to push the price higher, targeting 346.64 as the next resistance level. If momentum continues, a test of 350.87 is possible, with a strong session potentially driving Tesla to the high bull target of 363.84.</p>
<p>Failure to hold 340.97 could result in bearish control, leading to a test at 333.93. Continued selling pressure may bring 327.59 into play, and a breakdown here could see Tesla moving toward the low bear target of 322.52.</p>
<p>Final Word:&nbsp; The final session of the week brings a series of significant economic releases. At 9:45 AM ET, we&rsquo;ll see the Preliminary S&amp;P Global Services, Composite, and Manufacturing PMI reports for November, providing insight into the economic landscape. Shortly after, at 10:00 AM ET, the University of Michigan&rsquo;s final sentiment reading for November, along with 1-year and 5-10 year inflation expectations, will take center stage.</p>
<p>Finally, at 11:00 AM ET, the Kansas City Fed Services Activity index for November will offer additional data for market participants to digest. With multiple key indicators on the docket, expect volatility to be heightened. Stay vigilant, monitor volume and price action closely, and approach the day with disciplined risk management. Good luck and Happy Friday!</p>
<p>The Morning Memo is curated by RIPS, a pro trader with years of experience in equities, options, and futures trading. RIPS is at the heart of the exclusive Market Clubhouse community, offering his insights, expertise, and real-time mentorship.</p>
<p>Start your day with a live daily market analysis, a carefully selected watch list, early access to the Morning Memo, and exclusive Market Clubhouse price levels, providing precise support and resistance indicators. When you become a member of Market Clubhouse, you will gain early access to the Morning Memo, just like this one, every single day&mdash;hours before it&#39;s published. You will also have access to a live stream with zero latency and screen sharing, enabling you to witness Rips executing his trades in real-time and sharing his exclusive trading plans, strategies, and live decision-making.</p>
<p>For a limited time during our special promotion, you can join RIPS and get a full access pass to Market Clubhouse for 7 full days for just $7. Check it out at <a href="https://marketclubhouse.club/7Days/" title="https://marketclubhouse.club/7Days/">https://marketclubhouse.club/7Days/</a> where you can trade live with him and tap into his wealth of knowledge and experience. You can also catch Rips on his live day trading streams every Monday-Friday at 8 am EST on the Market Clubhouse YouTube channel: <a href="https://www.youtube.com/@MarketClubhouse" title="https://www.youtube.com/@MarketClubhouse">https://www.youtube.com/@MarketClubhouse</a>.</p>
<p class="contributor-disclaimer"><em>This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.</em></p>


General

AAPL

GOOGL

MSFT

NVDA

Market Clubhouse Morning Memo - November 22nd, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)

DANOY

LWAY

Edward And Ludmila Smolyansky Urge Lifeway Foods To Form Special Committee To Evaluate Danone's $27 Per Share Cash Offer Amid Board's Rejection And Legal Disputes

<p>JP Morgan  analyst Pinjalim Bora   maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Overweight and raises the price target from $100 to $130.</p>


JP Morgan Maintains Overweight on Elastic, Raises Price Target to $130

<p>Benchmark  analyst Fawne Jiang   reiterates iQIYI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQ#NASDAQ">IQ</a>) with a Hold.</p>


Reiteration

Benchmark Reiterates Hold on iQIYI

Macro Economic Events

Econ #s

Economics

USA S&P Global Services PMI For November 57.0 Vs 55.2 Est.; 55.0 Prior

Viatris Inc. 2024 Q3 - Results - Earnings Call Presentation

Analyst Jason Gerberry from Bank of America Securities reiterated a Sell rating on Viatris (VTRS – Research Report) and keeping the price target at...

Viatris Underperform Rating: Limited Growth Prospects and Conservative Capital Allocation Strategy

Bargain Priced Viatris Reports Strong Q3 Earnings Results

14 out of 18 healthcare companies beat profit estimates this week- Earnings scorecard

Viatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript)

There are endless ways of analyzing price data. But the truth is, I don't use 90% of it. What I find most useful when analyzing stock charts is pattern recognition. Today, I'll review three of the patterns that I use regularly in my trading research.

3 Chart Patterns That Cut Through The Market's Chaos

Bristol-Myers Squibb: Buy This Bargain Before It's Gone

How I Repurposed My Late Father's Trust Account

Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)

Viatris fined £1.5M for failure to comply with CMA order

ABBV

AMRX

ANGL

AZNCF

BMYMP

CPRJ

CPRO

CSCO

DOCS

GILD

IBHE

LEGN

MRNA

REGN

SPGI

TEVA

TMHC

VTRS

Screenshot 2024-09-30 at 5.38.54 PM

Biotech

Movers & Shakers

COSM

Nestle Sponsored representing Registered Shares Series B

NSRGY

How Cosmos Health&#39;s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

How Cosmos Health's Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

Press Releases

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)

Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe

Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe

Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference

Viatris Named to Forbes' World's Top Companies for Women 2024 List

Dividends

Viatris Announces Third Quarter 2024 Dividend

Earnings

Viatris Reports Third Quarter Financial Results for 2024

LXRX

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Catalent

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Intra-Cellular Therapies Inc. - Common Stock

Intra-Cellular Therapies

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Organon

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Comments

Viatris

Notizie

Ultime notizie per Viatris (NASDAQ:VTRS) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO